Search
Close this search box.

Modifying Diet to Improve Gut Microbiome

Studies

Study First Submitted Date 2019-03-25
Study First Posted Date 2019-04-23
Last Update Posted Date 2023-06-22
Start Month Year June 2024
Primary Completion Month Year June 2025
Verification Month Year June 2023
Verification Date 2023-06-30
Last Update Posted Date 2023-06-22

Facilities

Sequence: 200842267
Name Moffit Cancer Center
City Tampa
State Florida
Zip 33612
Country United States

Facility Contacts

Sequence: 28233221
Facility Id 200842267
Contact Type primary
Name Tiffany Carson, PhD
Email Tiffany.Carson@moffitt.org
Phone 813-745-4944

Facility Investigators

Sequence: 18411620
Facility Id 200842267
Role Principal Investigator
Name Tiffany Carson, PhD

Conditions

Sequence: 52393136
Name Obesity
Downcase Name obesity

Id Information

Sequence: 40316466
Id Source org_study_id
Id Value IRB-300003207

Countries

Sequence: 42739576
Name United States
Removed False

Design Groups

Sequence: 55839984 Sequence: 55839985
Group Type Experimental Group Type Active Comparator
Title DASH diet Title standard American diet
Description calorie-restricted DASH diet (25% fat; 57% carbohydrate; 18% protein; 34 g fiber Description calorie-restricted standard American diet (35% fat; 51% carbohydrate; %15 protein; 14 g fiber

Interventions

Sequence: 52702912 Sequence: 52702913
Intervention Type Behavioral Intervention Type Behavioral
Name DASH diet Name standard American diet
Description brief description Description describe

Design Outcomes

Sequence: 178200566 Sequence: 178200567 Sequence: 178200568 Sequence: 178200569 Sequence: 178200570 Sequence: 178200571 Sequence: 178200572 Sequence: 178200573 Sequence: 178200574 Sequence: 178200575 Sequence: 178200576 Sequence: 178200577
Outcome Type primary Outcome Type primary Outcome Type primary Outcome Type primary Outcome Type primary Outcome Type primary Outcome Type primary Outcome Type primary Outcome Type primary Outcome Type primary Outcome Type primary Outcome Type primary
Measure Mean Weight Change of Participants Measure Mean Weight Change of Participants Measure Mean Weight Change of Participants Measure Diet-specific changes in secondary bile acid Measure Diet-specific changes in secondary bile acid Measure Diet-specific changes in secondary bile acid Measure Diet-specific changes in inflammatory marker Measure Diet-specific changes in inflammatory marker Measure Diet-specific changes in inflammatory marker Measure Diet-specific changes in short chain fatty acids Measure Diet-specific changes in short chain fatty acids Measure Diet-specific changes in short chain fatty acids
Time Frame Baseline to day 28 Time Frame Day 28 to Day 42 Time Frame Baseline to day 42 Time Frame Baseline to day 28 Time Frame day 28 to day 42 Time Frame baseline to day 42 Time Frame baseline to day 28 Time Frame day 28 to day 42 Time Frame baseline to day 42 Time Frame baseline to day 28 Time Frame day 28 to day 42 Time Frame baseline to day 42
Description Weight change as measured by a scale in kilograms at multiple time points will be calculated and averaged. Description Weight change as measured by a scale in kilograms at multiple time points will be calculated and averaged. Description Weight change as measured by a scale in kilograms at multiple time points will be calculated and averaged. Description The investigators will calculate changes in cholic acid in milligrams. Description The investigators will calculate changes in cholic acid in milligrams. Description The investigators will calculate changes in cholic acid in milligrams. Description The investigators will calculate changes in c-reactive protein in mg/L. Description The investigators will calculate changes in c-reactive protein in mg/L. Description The investigators will calculate changes in c-reactive protein in mg/L. Description The investigators will calculate changes in acetic acid in mmol/L Description The investigators will calculate changes in acetic acid in mmol/L Description The investigators will calculate changes in acetic acid in mmol/L

Browse Conditions

Sequence: 194329834 Sequence: 194329835 Sequence: 194329836 Sequence: 194329837 Sequence: 194329838
Mesh Term Obesity Mesh Term Overweight Mesh Term Overnutrition Mesh Term Nutrition Disorders Mesh Term Body Weight
Downcase Mesh Term obesity Downcase Mesh Term overweight Downcase Mesh Term overnutrition Downcase Mesh Term nutrition disorders Downcase Mesh Term body weight
Mesh Type mesh-list Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor

Sponsors

Sequence: 48525872
Agency Class OTHER
Lead Or Collaborator lead
Name H. Lee Moffitt Cancer Center and Research Institute

Overall Officials

Sequence: 29401548
Role Principal Investigator
Name Tiffany L Carson, PhD
Affiliation Moffitt Cancer Center

Central Contacts

Sequence: 12066212
Contact Type primary
Name Tiffany L Carson, PhD
Phone 813-745-4944
Email Tiffany.Carson@moffitt.org
Role Contact

Design Group Interventions

Sequence: 68450967 Sequence: 68450968
Design Group Id 55839984 Design Group Id 55839985
Intervention Id 52702912 Intervention Id 52702913

Eligibilities

Sequence: 30893483
Gender Female
Minimum Age 18 Years
Maximum Age N/A
Healthy Volunteers Accepts Healthy Volunteers
Criteria Inclusion Criteria:

female
non-Hispanic, black or white
age 19-65 years
BMI >= 30 kg/m^2
able to visit Bionutrition Unit daily

Exclusion Criteria:

gastrointestinal (GI) conditions i.e., irritable bowel, diverticulitis, peptic ulcers, Crohn's, GI cancers, and adenatomous polyps
antibiotic or probiotic use in the previous 90 days
tobacco use
heavy alcohol consumption
major medical conditions (e.g., renal disease, diabetes, cancer)

Adult True
Child False
Older Adult True

Calculated Values

Sequence: 254137173
Number Of Facilities 1
Registered In Calendar Year 2019
Were Results Reported False
Has Us Facility True
Has Single Facility True
Minimum Age Num 18
Minimum Age Unit Years
Number Of Primary Outcomes To Measure 12

Designs

Sequence: 30639226
Allocation Randomized
Intervention Model Parallel Assignment
Observational Model
Primary Purpose Treatment
Time Perspective
Masking None (Open Label)

Responsible Parties

Sequence: 29005837
Responsible Party Type Sponsor